DK2001499T3 - Anvendelse af TGS-6 til behandling af osteoporose - Google Patents

Anvendelse af TGS-6 til behandling af osteoporose

Info

Publication number
DK2001499T3
DK2001499T3 DK07712838.7T DK07712838T DK2001499T3 DK 2001499 T3 DK2001499 T3 DK 2001499T3 DK 07712838 T DK07712838 T DK 07712838T DK 2001499 T3 DK2001499 T3 DK 2001499T3
Authority
DK
Denmark
Prior art keywords
tgs
osteoporosis
treatment
Prior art date
Application number
DK07712838.7T
Other languages
Danish (da)
English (en)
Inventor
Afsie Sabokbar
Anthony Day
Caroline Milner
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manchester filed Critical Univ Manchester
Application granted granted Critical
Publication of DK2001499T3 publication Critical patent/DK2001499T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK07712838.7T 2006-03-06 2007-03-06 Anvendelse af TGS-6 til behandling af osteoporose DK2001499T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0604460.6A GB0604460D0 (en) 2006-03-06 2006-03-06 Treatment
PCT/GB2007/000772 WO2007101988A2 (en) 2006-03-06 2007-03-06 Use of tsg-6 for treating bone diseases

Publications (1)

Publication Number Publication Date
DK2001499T3 true DK2001499T3 (da) 2013-09-08

Family

ID=36219200

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07712838.7T DK2001499T3 (da) 2006-03-06 2007-03-06 Anvendelse af TGS-6 til behandling af osteoporose

Country Status (7)

Country Link
US (1) US9066908B2 (enExample)
EP (1) EP2001499B1 (enExample)
JP (1) JP5346216B2 (enExample)
DK (1) DK2001499T3 (enExample)
ES (1) ES2426196T3 (enExample)
GB (1) GB0604460D0 (enExample)
WO (1) WO2007101988A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609334B2 (en) 2008-05-29 2013-12-17 The Regents Of The University Of California Biomarkers for painful intervertebral discs and methods of use thereof
US9675665B2 (en) 2013-12-18 2017-06-13 The Texas A & M University System Treatment of gum diseases and gum disorders with TSG-6 protein
GB201910645D0 (en) * 2019-07-25 2019-09-11 Univ Manchester Treatment for dry eye disease
CN111273029B (zh) * 2020-02-25 2023-03-31 芜湖天明生物技术有限公司 rhTSG-6双抗体夹心ELISA法定量检测试剂盒及其使用方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
ATE185573T1 (de) * 1991-01-14 1999-10-15 Univ New York Cytokin-induziertes protein, tsg-6, seine dna und verwendung
EP0705842A2 (en) 1994-10-06 1996-04-10 Hoechst Aktiengesellschaft Regulated genes by stimulation of chondrocytes with 1L-1beta
WO1997004075A1 (en) 1995-07-20 1997-02-06 New York University Pharmaceutical compositions containing tsg-6 for treating inflammatory diseases and cancer-related pathologies and methods
JP2003521216A (ja) * 1997-08-05 2003-07-15 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ９０個のヒト分泌タンパク質
AU2002253133B2 (en) 2001-04-03 2008-02-28 Societe Des Produits Nestle S.A. Osteoprotegerin in milk
ITRM20030595A1 (it) 2003-12-23 2005-06-24 Sigma Tau Ind Farmaceuti Uso della ptx3 o di un suo derivato funzionale da sola o in associazione con tsg6 per il trattamento di patologie degenarative dell'osso o della cartilagine e per il trattamento della infertilita' femminile.

Also Published As

Publication number Publication date
WO2007101988A2 (en) 2007-09-13
EP2001499A2 (en) 2008-12-17
ES2426196T3 (es) 2013-10-21
US20090099084A1 (en) 2009-04-16
US9066908B2 (en) 2015-06-30
GB0604460D0 (en) 2006-04-12
JP5346216B2 (ja) 2013-11-20
JP2009532334A (ja) 2009-09-10
EP2001499B1 (en) 2013-06-05
WO2007101988A3 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
DK2137537T3 (da) Sammensætninger og anvendelser til behandling af multipel sklerose
ATE477312T1 (de) Flüssigkeitshärtung
DK2061561T3 (da) Sammensætninger til behandling af cancer
BRPI0813546A2 (pt) interface ortopédica
ES1063346Y (es) Andador
EP2037789A4 (en) BLENDER
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
EP3329912C0 (en) LIQUID COMPOSITION
DK2079485T3 (da) Phenylpropionamidforbindelser og anvendelsen deraf
DK2235002T3 (da) 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
DK2101805T3 (da) Integrinligander til anvendelse i behandling af cancer
HRP20141261T1 (xx) Spojevi tioninija i njihove uporabe
DK2200600T3 (da) Neramexan til anvendelse ved behandlingen af subakut tinnitus
DK2004183T3 (da) Mazindol-kombination i behandlingen af opmærksomhedsunderskud/hyperaktivitet
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
DE602007000495D1 (de) Flüssigkeit-Koinfusionsgerät
DK2173831T3 (da) Brøndbehandling
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
BRPI0813116A2 (pt) Tornozeleira e kit de tornozeleira
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
EP2216574A4 (en) MIXER
DE602007003905D1 (de) Verbinder
DE602007001119D1 (de) Verbinder
DK2001499T3 (da) Anvendelse af TGS-6 til behandling af osteoporose
BRPI0817439A2 (pt) gaseificador